Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The Opioid-induced Constipation is expected to grow from USD XX.0 million in 2018 to XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 7.8% during the forecast period. The research provides insights for the global Opioid-induced Constipation market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.
A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Opioid-induced Constipation industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.
The Snapshot of Global Opioid-induced Constipation Market Segmentations:
By Players:
Abbott
Pfizer
SLA Pharma
Valeant Pharmaceuticals International
AstraZeneca
Progenics Pharmaceuticals
Johnson & Johnson
Merck
Daewoong
GlaxoSmithKline
Theravance
Daiichi Sankyo
Boehringer Ingelheim
Nektar Therapeutics
Ironwood Pharmaceuticals
Bayer
Synergy Pharmaceuticals
Mundipharma
Cosmo Pharmaceuticals
Shionogi
Takeda Pharmaceutical
Sucampo
By Types:
Solid
Liquid
By End-User:
Drugstore
Hospital
Others
By Regions:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
France
-
Italy
-
Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)
-
Spain
-
Belgium
-
Poland
-
Russia
-
Turkey
-
Others
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Australia and New Zealand
-
ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)
Latin America, Middle East & Africa
-
GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)
-
Brazil
-
Nigeria
-
South Africa
-
Argentina
-
Others
Table of Contents
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Opioid-induced Constipation Market
-
1.3 Market Segmentation by Type
-
1.3.1 Global Opioid-induced Constipation Market Share by Types
1.3.2 Global Opioid-induced Constipation Market Size and Growth Rate of Solid from 2014 to 2026
1.3.3 Global Opioid-induced Constipation Market Size and Growth Rate of Liquid from 2014 to 2026
-
1.4 Market Segmentation by End-Users
-
1.4.1 Global Opioid-induced Constipation Market Share by End-Users
1.4.2 Global Opioid-induced Constipation Market Size and Growth Rate of Drugstore from 2014 to 2026
1.4.3 Global Opioid-induced Constipation Market Size and Growth Rate of Hospital from 2014 to 2026
1.4.4 Global Opioid-induced Constipation Market Size and Growth Rate of Others from 2014 to 2026
-
1.5 Market Segmentation by Regions
-
1.5.1 North America Opioid-induced Constipation Market Size and Growth Rate from 2014 to 2026
-
1.5.1.1 United States Opioid-induced Constipation Market Size and Growth Rate from 2014 to 2026
-
1.5.1.2 Canada Opioid-induced Constipation Market Size and Growth Rate from 2014 to 2026
-
1.5.1.3 Mexico Opioid-induced Constipation Market Size and Growth Rate from 2014 to 2026
-
1.5.2 Europe Opioid-induced Constipation Market Size and Growth Rate from 2014 to 2026
-
1.5.2.1 Germany Opioid-induced Constipation Market Size and Growth Rate from 2014 to 2026
-
1.5.2.2 UK Opioid-induced Constipation Market Size and Growth Rate from 2014 to 2026
-
1.5.2.3 France Opioid-induced Constipation Market Size and Growth Rate from 2014 to 2026
-
1.5.2.4 Italy Opioid-induced Constipation Market Size and Growth Rate from 2014 to 2026
-
1.5.2.5 Nordic Countries Opioid-induced Constipation Market Size and Growth Rate from 2014 to 2026
-
1.5.2.6 Spain Opioid-induced Constipation Market Size and Growth Rate from 2014 to 2026
-
1.5.2.7 Belgium Opioid-induced Constipation Market Size and Growth Rate from 2014 to 2026
-
1.5.2.8 Poland Opioid-induced Constipation Market Size and Growth Rate from 2014 to 2026
-
1.5.2.9 Russia Opioid-induced Constipation Market Size and Growth Rate from 2014 to 2026
-
1.5.2.10 Turkey Opioid-induced Constipation Market Size and Growth Rate from 2014 to 2026
-
1.5.3 Asia-Pacific Opioid-induced Constipation Market Size and Growth Rate from 2014 to 2026
-
1.5.3.1 China Opioid-induced Constipation Market Size and Growth Rate from 2014 to 2026
-
1.5.3.2 Japan Opioid-induced Constipation Market Size and Growth Rate from 2014 to 2026
-
1.5.3.3 Australia and New Zealand Opioid-induced Constipation Market Size and Growth Rate from 2014 to 2026
-
1.5.3.4 India Opioid-induced Constipation Market Size and Growth Rate from 2014 to 2026
-
1.5.3.5 ASEAN Countries Opioid-induced Constipation Market Size and Growth Rate from 2014 to 2026
-
1.5.3.6 South Korea Opioid-induced Constipation Market Size and Growth Rate from 2014 to 2026
-
1.5.4 Latin America, Middle East & Africa Opioid-induced Constipation Market Size and Growth Rate from 2014 to 2026
-
1.5.4.1 GCC Countries Opioid-induced Constipation Market Size and Growth Rate from 2014 to 2026
-
1.5.4.2 Brazil Opioid-induced Constipation Market Size and Growth Rate from 2014 to 2026
-
1.5.4.3 Nigeria Opioid-induced Constipation Market Size and Growth Rate from 2014 to 2026
-
1.5.4.4 South Africa Opioid-induced Constipation Market Size and Growth Rate from 2014 to 2026
-
1.5.4.5 Argentina Opioid-induced Constipation Market Size and Growth Rate from 2014 to 2026
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
3 Segmentation of Opioid-induced Constipation Market by Types
-
3.1 Product Development Trends of Different Types
-
3.2 Commercial Product Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Opioid-induced Constipation by Major Types
3.4.1 Market Size and Growth Rate of Solid
3.4.2 Market Size and Growth Rate of Liquid
4 Segmentation of Opioid-induced Constipation Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Opioid-induced Constipation by Major End-Users
4.4.1 Market Size and Growth Rate of Opioid-induced Constipation for Drugstore
4.4.2 Market Size and Growth Rate of Opioid-induced Constipation for Hospital
4.4.3 Market Size and Growth Rate of Opioid-induced Constipation for Others
5 Market Analysis by Major Regions
-
5.1 Global Opioid-induced Constipation Production Analysis by Major Regions
-
5.2 Global Opioid-induced Constipation Consumption Analysis by Major Regions
-
5.3 Global Opioid-induced Constipation Production, Import, Consumption and Export Analysis by Regions
-
5.3.1 North America Opioid-induced Constipation Production, Import, Consumption and Export Analysis
-
5.3.2 Europe Opioid-induced Constipation Production, Import, Consumption and Export Analysis
-
5.3.3 Asia Pacific Opioid-induced Constipation Production, Import, Consumption and Export Analysis
-
5.3.4 Latin America, Middle East & Africa Opioid-induced Constipation Production, Import, Consumption and Export Analysis
6 Product Commodity of Opioid-induced Constipation Market in Major Countries
-
6.1 Top 5 Export Countries in Opioid-induced Constipation market from 2014 to 2019
-
6.1.1 Top 5 Export Countries' Export Value Analysis in Opioid-induced Constipation market from 2014 to 2019
-
6.1.2 Top 5 Export Countries' Export Volume Analysis in Opioid-induced Constipation market from 2014 to 2019
-
6.2 Top 5 Import Countries in Opioid-induced Constipation market from 2014 to 2019
-
6.2.1 Top 5 Import Countries' Import Value Analysis in Opioid-induced Constipation market from 2014 to 2019
-
6.2.2 Top 5 Import Countries' Import Volume Analysis in Opioid-induced Constipation market from 2014 to 2019
-
6.3 Emerging Top 3 Export Countries Analysis
-
6.4 Emerging Top 3 Import Countries Analysis
7 North America Opioid-induced Constipation Landscape Analysis
-
7.1 North America Opioid-induced Constipation Landscape Analysis by Major Types
-
7.2 North America Opioid-induced Constipation Landscape Analysis by Major End-Users
-
7.3 North America Opioid-induced Constipation Landscape Analysis by Major Countries
-
7.3.1 United States Opioid-induced Constipation Market Volume and Growth Rate
-
7.3.2 Canada Opioid-induced Constipation Market Volume and Growth Rate
-
7.3.3 Mexico Opioid-induced Constipation Market Volume and Growth Rate
8 Europe Opioid-induced Constipation Landscape Analysis
-
8.1 Europe Opioid-induced Constipation Landscape Analysis by Major Types
-
8.2 Europe Opioid-induced Constipation Landscape Analysis by Major End-Users
-
8.3 Europe Opioid-induced Constipation Landscape Analysis by Major Countries
-
8.3.1 Germany Opioid-induced Constipation Market Volume and Growth Rate
-
8.3.2 UK Opioid-induced Constipation Market Volume and Growth Rate
-
8.3.3 France Opioid-induced Constipation Market Volume and Growth Rate
-
8.3.4 Italy Opioid-induced Constipation Market Volume and Growth Rate
-
8.3.5 Nordic Countries Opioid-induced Constipation Market Volume and Growth Rate
-
8.3.6 Spain Opioid-induced Constipation Market Volume and Growth Rate
-
8.3.7 Belgium Opioid-induced Constipation Market Volume and Growth Rate
-
8.3.8 Poland Opioid-induced Constipation Market Volume and Growth Rate
-
8.3.9 Russia Opioid-induced Constipation Market Volume and Growth Rate
-
8.3.10 Turkey Opioid-induced Constipation Market Volume and Growth Rate
9 Asia Pacific Opioid-induced Constipation Landscape Analysis
-
9.1 Asia Pacific Opioid-induced Constipation Landscape Analysis by Major Types
-
9.2 Asia Pacific Opioid-induced Constipation Landscape Analysis by Major End-Users
-
9.3 Asia Pacific Opioid-induced Constipation Landscape Analysis by Major Countries
-
9.3.1 China Opioid-induced Constipation Market Volume and Growth Rate
-
9.3.2 Japan Opioid-induced Constipation Market Volume and Growth Rate
-
9.3.3 Australia and New Zealand Opioid-induced Constipation Market Volume and Growth Rate
-
9.3.4 India Opioid-induced Constipation Market Volume and Growth Rate
-
9.3.5 ASEAN Countries Opioid-induced Constipation Market Volume and Growth Rate
-
9.3.6 South Korea Opioid-induced Constipation Market Volume and Growth Rate
10 Latin America, Middle East & Africa Opioid-induced Constipation Landscape Analysis
-
10.1 Latin America, Middle East & Africa Opioid-induced Constipation Landscape Analysis by Major Types
-
10.2 Latin America, Middle East & Africa Opioid-induced Constipation Landscape Analysis by Major End-Users
-
10.3 Latin America, Middle East & Africa Opioid-induced Constipation Landscape Analysis by Major Countries
-
10.3.1 GCC Countries Opioid-induced Constipation Market Volume and Growth Rate
-
10.3.2 Brazil Opioid-induced Constipation Market Volume and Growth Rate
-
10.3.3 Nigeria Opioid-induced Constipation Market Volume and Growth Rate
-
10.3.4 South Africa Opioid-induced Constipation Market Volume and Growth Rate
-
10.3.5 Argentina Opioid-induced Constipation Market Volume and Growth Rate
11 Major Players Profile
11.1 Abbott
11.1.1 Abbott Company Profile and Development Status
11.1.2 Market Performance
11.1.3 Product and Service Introduction
11.2 Pfizer
11.2.1 Pfizer Company Profile and Development Status
11.2.2 Market Performance
11.2.3 Product and Service Introduction
11.3 SLA Pharma
11.3.1 SLA Pharma Company Profile and Development Status
11.3.2 Market Performance
11.3.3 Product and Service Introduction
11.4 Valeant Pharmaceuticals International
11.4.1 Valeant Pharmaceuticals International Company Profile and Development Status
11.4.2 Market Performance
11.4.3 Product and Service Introduction
11.5 AstraZeneca
11.5.1 AstraZeneca Company Profile and Development Status
11.5.2 Market Performance
11.5.3 Product and Service Introduction
11.6 Progenics Pharmaceuticals
11.6.1 Progenics Pharmaceuticals Company Profile and Development Status
11.6.2 Market Performance
11.6.3 Product and Service Introduction
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Profile and Development Status
11.7.2 Market Performance
11.7.3 Product and Service Introduction
11.8 Merck
11.8.1 Merck Company Profile and Development Status
11.8.2 Market Performance
11.8.3 Product and Service Introduction
11.9 Daewoong
11.9.1 Daewoong Company Profile and Development Status
11.9.2 Market Performance
11.9.3 Product and Service Introduction
11.10 GlaxoSmithKline
11.10.1 GlaxoSmithKline Company Profile and Development Status
11.10.2 Market Performance
11.10.3 Product and Service Introduction
11.11 Theravance
11.11.1 Theravance Company Profile and Development Status
11.11.2 Market Performance
11.11.3 Product and Service Introduction
11.12 Daiichi Sankyo
11.12.1 Daiichi Sankyo Company Profile and Development Status
11.12.2 Market Performance
11.12.3 Product and Service Introduction
11.13 Boehringer Ingelheim
11.13.1 Boehringer Ingelheim Company Profile and Development Status
11.13.2 Market Performance
11.13.3 Product and Service Introduction
11.14 Nektar Therapeutics
11.14.1 Nektar Therapeutics Company Profile and Development Status
11.14.2 Market Performance
11.14.3 Product and Service Introduction
11.15 Ironwood Pharmaceuticals
11.15.1 Ironwood Pharmaceuticals Company Profile and Development Status
11.15.2 Market Performance
11.15.3 Product and Service Introduction
11.16 Bayer
11.16.1 Bayer Company Profile and Development Status
11.16.2 Market Performance
11.16.3 Product and Service Introduction
11.17 Synergy Pharmaceuticals
11.17.1 Synergy Pharmaceuticals Company Profile and Development Status
11.17.2 Market Performance
11.17.3 Product and Service Introduction
11.18 Mundipharma
11.18.1 Mundipharma Company Profile and Development Status
11.18.2 Market Performance
11.18.3 Product and Service Introduction
11.19 Cosmo Pharmaceuticals
11.19.1 Cosmo Pharmaceuticals Company Profile and Development Status
11.19.2 Market Performance
11.19.3 Product and Service Introduction
11.20 Shionogi
11.20.1 Shionogi Company Profile and Development Status
11.20.2 Market Performance
11.20.3 Product and Service Introduction
11.21 Takeda Pharmaceutical
11.21.1 Takeda Pharmaceutical Company Profile and Development Status
11.21.2 Market Performance
11.21.3 Product and Service Introduction
11.22 Sucampo
11.22.1 Sucampo Company Profile and Development Status
11.22.2 Market Performance
11.22.3 Product and Service Introduction
12 Data Source and Research Methodology
The List of Tables and Figures (Totals 85 Figures and 165 Tables)
-
Figure Product Picture
Figure Global Opioid-induced Constipation Market Size and Growth Rate of Solid from 2014 to 2026
Figure Global Opioid-induced Constipation Market Size and Growth Rate of Liquid from 2014 to 2026
-
Figure Market Share by Type in 2014
-
Figure Market Share by Type in 2018
-
Figure Market Share by Type in 2026
Figure Global Opioid-induced Constipation Market Size and Growth Rate of Drugstore from 2014 to 2026
Figure Global Opioid-induced Constipation Market Size and Growth Rate of Hospital from 2014 to 2026
Figure Global Opioid-induced Constipation Market Size and Growth Rate of Others from 2014 to 2026
-
Figure Market Share by End-User in 2014
-
Figure Market Share by End-User in 2018
-
Figure Market Share by End-User in 2026
-
Figure North America Opioid-induced Constipation Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure United States Opioid-induced Constipation Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Canada Opioid-induced Constipation Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Mexico Opioid-induced Constipation Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Europe Opioid-induced Constipation Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Germany Opioid-induced Constipation Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure UK Opioid-induced Constipation Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure France Opioid-induced Constipation Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Italy Opioid-induced Constipation Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Nordic Countries Opioid-induced Constipation Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Spain Opioid-induced Constipation Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Belgium Opioid-induced Constipation Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Poland Opioid-induced Constipation Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Russia Opioid-induced Constipation Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Turkey Opioid-induced Constipation Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Asia-Pacific Opioid-induced Constipation Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure China Opioid-induced Constipation Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Japan Opioid-induced Constipation Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Australia and New Zealand Opioid-induced Constipation Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure India Opioid-induced Constipation Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure ASEAN Countries Opioid-induced Constipation Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure South Korea Opioid-induced Constipation Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Latin America, Middle East & Africa Opioid-induced Constipation Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure GCC Countries Opioid-induced Constipation Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Brazil Opioid-induced Constipation Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Nigeria Opioid-induced Constipation Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure South Africa Opioid-induced Constipation Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Argentina Opioid-induced Constipation Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Development Trends and Industry Dynamics of Opioid-induced Constipation Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2018
-
Figure Market Share of TOP 5 Players in 2018
-
Figure Market Share of TOP 6 Players from 2014 to 2019
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Table Specifications of Different Types of Opioid-induced Constipation
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Opioid-induced Constipation by Different Types from 2014 to 2026
-
Table Consumption Share of Opioid-induced Constipation by Different Types from 2014 to 2026
Figure Market Size and Growth Rate of Solid
Figure Market Size and Growth Rate of Liquid
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Table Consumption of Opioid-induced Constipation by Different End-Users from 2014 to 2026
-
Table Consumption Share of Opioid-induced Constipation by Different End-Users from 2014 to 2026
Figure Market Size and Growth Rate of Drugstore
Figure Market Size and Growth Rate of Hospital
Figure Market Size and Growth Rate of Others
-
Table Global Opioid-induced Constipation Production by Major Regions
-
Table Global Opioid-induced Constipation Production Share by Major Regions
-
Figure Global Opioid-induced Constipation Production Share by Major Regions in 2014
-
Figure Global Opioid-induced Constipation Production Share by Major Regions in 2018
-
Figure Global Opioid-induced Constipation Production Share by Major Regions in 2026
-
Table Global Opioid-induced Constipation Consumption by Major Regions
-
Table Global Opioid-induced Constipation Consumption Share by Major Regions
-
Figure Global Opioid-induced Constipation Consumption Share by Major Regions in 2014
-
Figure Global Opioid-induced Constipation Consumption Share by Major Regions in 2018
-
Figure Global Opioid-induced Constipation Consumption Share by Major Regions in 2026
-
Table North America Opioid-induced Constipation Production, Import, Consumption and Export Analysis
-
Table Europe Opioid-induced Constipation Production, Import, Consumption and Export Analysis
-
Table Asia Pacific Opioid-induced Constipation Production, Import, Consumption and Export Analysis
-
Table Latin America, Middle East & Africa Opioid-induced Constipation Production, Import, Consumption and Export Analysis
-
Table Top 5 Export Countries' Export Value Analysis in Opioid-induced Constipation market from 2014 to 2019
-
Table Top 5 Export Countries' Export Volume Analysis in Opioid-induced Constipation market from 2014 to 2019
-
Table Top 5 Import Countries' Import Value Analysis in Opioid-induced Constipation market from 2014 to 2019
-
Table Top 5 Import Countries' Import Volume Analysis in Opioid-induced Constipation market from 2014 to 2019
-
Figure Emerging Top 3 Export Countries Analysis
-
Figure Emerging Top 3 Import Countries Analysis
-
Table North America Opioid-induced Constipation Consumption by Types from 2014 to 2026
-
Table North America Opioid-induced Constipation Consumption Share by Types from 2014 to 2026
-
Figure North America Opioid-induced Constipation Consumption Share by Types in 2014
-
Figure North America Opioid-induced Constipation Consumption Share by Types in 2018
-
Figure North America Opioid-induced Constipation Consumption Share by Types in 2026
-
Table North America Opioid-induced Constipation Consumption by End-Users from 2014 to 2026
-
Table North America Opioid-induced Constipation Consumption Share by End-Users from 2014 to 2026
-
Figure North America Opioid-induced Constipation Consumption Share by End-Users in 2014
-
Figure North America Opioid-induced Constipation Consumption Share by End-Users in 2018
-
Figure North America Opioid-induced Constipation Consumption Share by End-Users in 2026
-
Table North America Opioid-induced Constipation Consumption by Major Countries from 2014 to 2026
-
Table North America Opioid-induced Constipation Consumption Share by Major Countries from 2014 to 2026
-
Figure North America Opioid-induced Constipation Consumption Share by Major Countries in 2014
-
Figure North America Opioid-induced Constipation Consumption Share by Major Countries in 2018
-
Figure North America Opioid-induced Constipation Consumption Share by Major Countries in 2026
-
Figure United States Opioid-induced Constipation Market Volume and Growth Rate from 2014 to 2026
-
Figure Canada Opioid-induced Constipation Market Volume and Growth Rate from 2014 to 2026
-
Figure Mexico Opioid-induced Constipation Market Volume and Growth Rate from 2014 to 2026
-
Table Europe Opioid-induced Constipation Consumption by Types from 2014 to 2026
-
Table Europe Opioid-induced Constipation Consumption Share by Types from 2014 to 2026
-
Figure Europe Opioid-induced Constipation Consumption Share by Types in 2014
-
Figure Europe Opioid-induced Constipation Consumption Share by Types in 2018
-
Figure Europe Opioid-induced Constipation Consumption Share by Types in 2026
-
Table Europe Opioid-induced Constipation Consumption by End-Users from 2014 to 2026
-
Table Europe Opioid-induced Constipation Consumption Share by End-Users from 2014 to 2026
-
Figure Europe Opioid-induced Constipation Consumption Share by End-Users in 2014
-
Figure Europe Opioid-induced Constipation Consumption Share by End-Users in 2018
-
Figure Europe Opioid-induced Constipation Consumption Share by End-Users in 2026
-
Table Europe Opioid-induced Constipation Consumption by Major Countries from 2014 to 2026
-
Table Europe Opioid-induced Constipation Consumption Share by Major Countries from 2014 to 2026
-
Figure Europe Opioid-induced Constipation Consumption Share by Major Countries in 2014
-
Figure Europe Opioid-induced Constipation Consumption Share by Major Countries in 2018
-
Figure Europe Opioid-induced Constipation Consumption Share by Major Countries in 2026
-
Figure Germany Opioid-induced Constipation Market Volume and Growth Rate from 2014 to 2026
-
Figure UK Opioid-induced Constipation Market Volume and Growth Rate from 2014 to 2026
-
Figure France Opioid-induced Constipation Market Volume and Growth Rate from 2014 to 2026
-
Figure Italy Opioid-induced Constipation Market Volume and Growth Rate from 2014 to 2026
-
Figure Nordic Countries Opioid-induced Constipation Market Volume and Growth Rate from 2014 to 2026
-
Figure Belgium Opioid-induced Constipation Market Volume and Growth Rate from 2014 to 2026
-
Figure Poland Opioid-induced Constipation Market Volume and Growth Rate from 2014 to 2026
-
Figure Russia Opioid-induced Constipation Market Volume and Growth Rate from 2014 to 2026
-
Figure Turkey Opioid-induced Constipation Market Volume and Growth Rate from 2014 to 2026
-
Table Asia Pacific Opioid-induced Constipation Consumption by Types from 2014 to 2026
-
Table Asia Pacific Opioid-induced Constipation Consumption Share by Types from 2014 to 2026
-
Figure Asia Pacific Opioid-induced Constipation Consumption Share by Types in 2014
-
Figure Asia Pacific Opioid-induced Constipation Consumption Share by Types in 2018
-
Figure Asia Pacific Opioid-induced Constipation Consumption Share by Types in 2026
-
Table Asia Pacific Opioid-induced Constipation Consumption by End-Users from 2014 to 2026
-
Table Asia Pacific Opioid-induced Constipation Consumption Share by End-Users from 2014 to 2026
-
Figure Asia Pacific Opioid-induced Constipation Consumption Share by End-Users in 2014
-
Figure Asia Pacific Opioid-induced Constipation Consumption Share by End-Users in 2018
-
Figure Asia Pacific Opioid-induced Constipation Consumption Share by End-Users in 2026
-
Table Asia Pacific Opioid-induced Constipation Consumption by Major Countries from 2014 to 2026
-
Table Asia Pacific Opioid-induced Constipation Consumption Share by Major Countries from 2014 to 2026
-
Figure Asia Pacific Opioid-induced Constipation Consumption Share by Major Countries in 2014
-
Figure Asia Pacific Opioid-induced Constipation Consumption Share by Major Countries in 2018
-
Figure Asia Pacific Opioid-induced Constipation Consumption Share by Major Countries in 2026
-
Figure China Opioid-induced Constipation Market Volume and Growth Rate from 2014 to 2026
-
Figure Japan Opioid-induced Constipation Market Volume and Growth Rate from 2014 to 2026
-
Figure Australia and New ZealandOpioid-induced Constipation Market Volume and Growth Rate from 2014 to 2026
-
Figure India Opioid-induced Constipation Market Volume and Growth Rate from 2014 to 2026
-
Figure ASEAN Countries Opioid-induced Constipation Market Volume and Growth Rate from 2014 to 2026
-
Figure South Korea Opioid-induced Constipation Market Volume and Growth Rate from 2014 to 2026
-
Table Latin America, Middle East & Africa Opioid-induced Constipation Consumption by Types from 2014 to 2026
-
Table Latin America, Middle East & Africa Opioid-induced Constipation Consumption Share by Types from 2014 to 2026
-
Figure Latin America, Middle East & Africa Opioid-induced Constipation Consumption Share by Types in 2014
-
Figure Latin America, Middle East & Africa Opioid-induced Constipation Consumption Share by Types in 2018
-
Figure Latin America, Middle East & Africa Opioid-induced Constipation Consumption Share by Types in 2026
-
Table Latin America, Middle East & Africa Opioid-induced Constipation Consumption by End-Users from 2014 to 2026
-
Table Latin America, Middle East & Africa Opioid-induced Constipation Consumption Share by End-Users from 2014 to 2026
-
Figure Latin America, Middle East & Africa Opioid-induced Constipation Consumption Share by End-Users in 2014
-
Figure Latin America, Middle East & Africa Opioid-induced Constipation Consumption Share by End-Users in 2018
-
Figure Latin America, Middle East & Africa Opioid-induced Constipation Consumption Share by End-Users in 2026
-
Table Latin America, Middle East & Africa Opioid-induced Constipation Consumption by Major Countries from 2014 to 2026
-
Table Latin America, Middle East & Africa Opioid-induced Constipation Consumption Share by Major Countries from 2014 to 2026
-
Figure Latin America, Middle East & Africa Opioid-induced Constipation Consumption Share by Major Countries in 2014
-
Figure Latin America, Middle East & Africa Opioid-induced Constipation Consumption Share by Major Countries in 2018
-
Figure Latin America, Middle East & Africa Opioid-induced Constipation Consumption Share by Major Countries in 2026
-
Figure GCC Countries Opioid-induced Constipation Market Volume and Growth Rate from 2014 to 2026
-
Figure Brazil Opioid-induced Constipation Market Volume and Growth Rate from 2014 to 2026
-
Figure Nigeria Opioid-induced Constipation Market Volume and Growth Rate from 2014 to 2026
-
Figure South Africa Opioid-induced Constipation Market Volume and Growth Rate from 2014 to 2026
-
Figure Argentina Opioid-induced Constipation Market Volume and Growth Rate from 2014 to 2026
Table Company Profile and Development Status of Abbott
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott
Figure Sales and Growth Rate Analysis of Abbott
Figure Revenue and Market Share Analysis of Abbott
Table Product and Service Introduction of Abbott
Table Company Profile and Development Status of Pfizer
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
Figure Sales and Growth Rate Analysis of Pfizer
Figure Revenue and Market Share Analysis of Pfizer
Table Product and Service Introduction of Pfizer
Table Company Profile and Development Status of SLA Pharma
Table Sales, Revenue, Sales Price and Gross Margin Analysis of SLA Pharma
Figure Sales and Growth Rate Analysis of SLA Pharma
Figure Revenue and Market Share Analysis of SLA Pharma
Table Product and Service Introduction of SLA Pharma
Table Company Profile and Development Status of Valeant Pharmaceuticals International
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Valeant Pharmaceuticals International
Figure Sales and Growth Rate Analysis of Valeant Pharmaceuticals International
Figure Revenue and Market Share Analysis of Valeant Pharmaceuticals International
Table Product and Service Introduction of Valeant Pharmaceuticals International
Table Company Profile and Development Status of AstraZeneca
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca
Figure Sales and Growth Rate Analysis of AstraZeneca
Figure Revenue and Market Share Analysis of AstraZeneca
Table Product and Service Introduction of AstraZeneca
Table Company Profile and Development Status of Progenics Pharmaceuticals
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Progenics Pharmaceuticals
Figure Sales and Growth Rate Analysis of Progenics Pharmaceuticals
Figure Revenue and Market Share Analysis of Progenics Pharmaceuticals
Table Product and Service Introduction of Progenics Pharmaceuticals
Table Company Profile and Development Status of Johnson & Johnson
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson
Figure Sales and Growth Rate Analysis of Johnson & Johnson
Figure Revenue and Market Share Analysis of Johnson & Johnson
Table Product and Service Introduction of Johnson & Johnson
Table Company Profile and Development Status of Merck
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck
Figure Sales and Growth Rate Analysis of Merck
Figure Revenue and Market Share Analysis of Merck
Table Product and Service Introduction of Merck
Table Company Profile and Development Status of Daewoong
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Daewoong
Figure Sales and Growth Rate Analysis of Daewoong
Figure Revenue and Market Share Analysis of Daewoong
Table Product and Service Introduction of Daewoong
Table Company Profile and Development Status of GlaxoSmithKline
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline
Figure Sales and Growth Rate Analysis of GlaxoSmithKline
Figure Revenue and Market Share Analysis of GlaxoSmithKline
Table Product and Service Introduction of GlaxoSmithKline
Table Company Profile and Development Status of Theravance
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Theravance
Figure Sales and Growth Rate Analysis of Theravance
Figure Revenue and Market Share Analysis of Theravance
Table Product and Service Introduction of Theravance
Table Company Profile and Development Status of Daiichi Sankyo
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Daiichi Sankyo
Figure Sales and Growth Rate Analysis of Daiichi Sankyo
Figure Revenue and Market Share Analysis of Daiichi Sankyo
Table Product and Service Introduction of Daiichi Sankyo
Table Company Profile and Development Status of Boehringer Ingelheim
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boehringer Ingelheim
Figure Sales and Growth Rate Analysis of Boehringer Ingelheim
Figure Revenue and Market Share Analysis of Boehringer Ingelheim
Table Product and Service Introduction of Boehringer Ingelheim
Table Company Profile and Development Status of Nektar Therapeutics
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nektar Therapeutics
Figure Sales and Growth Rate Analysis of Nektar Therapeutics
Figure Revenue and Market Share Analysis of Nektar Therapeutics
Table Product and Service Introduction of Nektar Therapeutics
Table Company Profile and Development Status of Ironwood Pharmaceuticals
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ironwood Pharmaceuticals
Figure Sales and Growth Rate Analysis of Ironwood Pharmaceuticals
Figure Revenue and Market Share Analysis of Ironwood Pharmaceuticals
Table Product and Service Introduction of Ironwood Pharmaceuticals
Table Company Profile and Development Status of Bayer
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer
Figure Sales and Growth Rate Analysis of Bayer
Figure Revenue and Market Share Analysis of Bayer
Table Product and Service Introduction of Bayer
Table Company Profile and Development Status of Synergy Pharmaceuticals
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Synergy Pharmaceuticals
Figure Sales and Growth Rate Analysis of Synergy Pharmaceuticals
Figure Revenue and Market Share Analysis of Synergy Pharmaceuticals
Table Product and Service Introduction of Synergy Pharmaceuticals
Table Company Profile and Development Status of Mundipharma
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mundipharma
Figure Sales and Growth Rate Analysis of Mundipharma
Figure Revenue and Market Share Analysis of Mundipharma
Table Product and Service Introduction of Mundipharma
Table Company Profile and Development Status of Cosmo Pharmaceuticals
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cosmo Pharmaceuticals
Figure Sales and Growth Rate Analysis of Cosmo Pharmaceuticals
Figure Revenue and Market Share Analysis of Cosmo Pharmaceuticals
Table Product and Service Introduction of Cosmo Pharmaceuticals
Table Company Profile and Development Status of Shionogi
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shionogi
Figure Sales and Growth Rate Analysis of Shionogi
Figure Revenue and Market Share Analysis of Shionogi
Table Product and Service Introduction of Shionogi
Table Company Profile and Development Status of Takeda Pharmaceutical
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda Pharmaceutical
Figure Sales and Growth Rate Analysis of Takeda Pharmaceutical
Figure Revenue and Market Share Analysis of Takeda Pharmaceutical
Table Product and Service Introduction of Takeda Pharmaceutical
Table Company Profile and Development Status of Sucampo
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sucampo
Figure Sales and Growth Rate Analysis of Sucampo
Figure Revenue and Market Share Analysis of Sucampo
Table Product and Service Introduction of Sucampo
-
